FSSAI issues notice to Dr Reddy's-Nestle JV over GLP-1 supplement claims

India's FSSAI issued notices to Dr Reddy's-Nestle joint venture for misleading claims on their Celevida GLP+ protein supplement. Claims like 'imported from Europe for purity' were flagged as ambiguous. Amazon and Flipkart also received notices as sellers. The product, launched in May, targets users of GLP-1 weight-loss and diabetes drugs.